Chancery Dismisses Challenge To $2.8B Genomic Health Sale
The Chancery Court has dismissed all claims in a stockholder suit alleging multiple conflicts and breaches of duty in Genomic Health Inc.'s $2.8 billion cash and stock sale to Exact Sciences...To view the full article, register now.
Already a subscriber? Click here to view full article